Taken together, this study identifies IMB-R38 as a novel RANKL/RANK inhibitor that functions as a dual regulator of bone formation and bone resorption in vitro and zebrafish osteoporosis models in vivo, with superior efficiency compared to Alen. The gene discussed is TNFRSF11A; the disease is osteoporosis.